...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Epigenetics market size

Very helpful post nbb.

As you pointed out 25 named but no RVX or ZCC? Where are RVX and ZCC? No profile after 21 years in the business.

There are 2 sides to this equation:

  1. Lots of high profile companies in this space hence the implication of many potential opportunities. The other implication is that with level of competition a top quality management is required for success.
  2. It's a highly competeitive space with numerous big players and lots of money to spend on R&D and the best scientists. How can an underfunded players like RVX and ZCC possibly compete? The BTD from the FDA should have at least put apabetalone on a high profile candidate list. No such luck.

From what I recall RVX and ZCC have approximately 4,000 molecules in their closet with only 2 in test (actually just 1 now). Don has stated many of times over my 14 years of involvement that there is an opportunity to license out some of the molecules to generate revenue but of course nothin had happened...not a penny generated.

Epigenetic Major Players Globe Newswire Jan 24 2024

Epigenetics market major players covered in the report, such as:

·       Thermo Fisher Scientific Inc (US)

·       Merck KGaA (Germany)

·       Illumina, Inc. (US)

·       PacBio (US)

·       Abcam plc (UK)

·       Active Motif, Inc. (US)

·       Bio-Rad Laboratories Inc. (US)

·       Promega Corporation (US)

·       Revvity (US)

·       Qiagen (Germany)

·       New England Biolabs (US)

·       Zymo Research Corporation (US)

·       Diagenode SA (US)

·       F. Hoffmann-La Roche Ltd (Switzerland)

·       EpiGentek Group Inc. (US)

·       EpiCypher (US)

·       Fios Genomics (UK)

·       GenomeScan (Netherlands)

·       Creative Biogene (US)

·       BPS Bioscience Inc. (US)

·       Abnova Corporation (Taiwan)

·       Creative Diagnostics (US)

·       biomodal (UK)

·       Integrated DNA Technologies Inc. (US)

·       Novogene Co. Ltd (China)

·       and Among Others

 

Final comment is this is an evolving, complex space with lots of potential but it will require big $$$ to compete.

GLTA

Toinv

 

 

Share
New Message
Please login to post a reply